Sort
51,593 grants matching “hepatitis”
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
$681,601Ana Krtolica · Omniox, Inc. · R44 · FY2019 · HD
Club Drug Use and HIV Risks among Minorities in NYC
$681,596Danielle C Ompad · New York Academy Of Medicine · R01 · FY2008 · DA
Development of a Urine Test for the Early Detection of Liver Cancer
$681,583Surbhi Jain · Jbs Science, Inc. · R44 · FY2013 · CA
Development of a novel drug candidate that inhibits hepatitis B virus covalently
$681,531Haitao Guo · Indiana University Indianapolis · R01 · FY2014 · AI
Metabolic Actions of FGF21
$681,470Eleftheria Maratos-Flier · Beth Israel Deaconess Medical Center · R01 · FY2011 · DK
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger
$681,414John V Frangioni · Beth Israel Deaconess Medical Center · R01 · FY2011 · EB
Risk Factors for Venous Thromboembolism in the Community
$681,242John A Heit · Mayo Clinic Rochester · R01 · FY2012 · HL
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
$681,204Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer
$681,100Ashutosh Chilkoti · Duke University · UH3 · FY2019 · CA
Evaluation of a community-based education, navigation, and support (CENS) intervention to reduce opioid-related harms among military veterans
$681,050Alexander S Bennett · New York University · R01 · FY2023 · DA
Structural and Mechanistic basis for RNA Silencing
$681,013Ian John Macrae · Scripps Research Institute, The · R35 · FY2023 · GM
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
$680,962Heidi M. Crane · University Of Washington · U01 · FY2019 · AA
HEPATITIS C: STUDIES OF IMMUNITY AND PATHOGENESIS
$680,907Rockefeller University · U19 · FY2000 · AI
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes
$680,901Samuel Klein · Remd Biotherapeutics, Inc. · R42 · FY2018 · DK
The role of liver progenitor cells in liver regeneration
$680,900Wolfram Goessling · Brigham And Women'S Hospital · R01 · FY2025 · DK
Integrating low-cost and versatile technologies to achieve colorimetric HCV and HIV detection from whole blood
$680,721Jesse Waggoner · Emory University · R01 · FY2024 · AI
Hepatic stellate cells in liver homeostasis and regeneration
$680,622Youngmin Anna Lee · Vanderbilt University Medical Center · R01 · FY2025 · DK
Understanding the Multilevel Drivers of Liver Cancer Disparities
$680,549Salma Shariff-Marco · University Of California, San Francisco · R01 · FY2019 · CA
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$680,547David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK
APO A-1 and Reverse Cholesterol Transport in Vivo
$680,520Daniel James Rader · Children'S Hosp Of Philadelphia · P01 · FY2007 · HL
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections
$680,423Shashi Kapadia · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DA
Development of FAPI PET as a Non-invasive Biomarker of Liver Fibrogenesis
$680,218Ali Pirasteh · University Of Wisconsin-Madison · R01 · FY2025 · DK
Drug eluting injectable biomaterials for next generation chemoembolization
$680,198Rahmi Oklu · Mayo Clinic Arizona · R01 · FY2021 · CA
Systemically restricted 5-HT2B antagonists for pulmonary arterial hypertension
$680,115William D Merryman · Vanderbilt University · R01 · FY2025 · HL
Testing of a Novel Inhaled Clofazimine (CFZ) Dry Powder Formulation in a Mouse Model of Mycobacterium tuberculosis
$680,009Janice Endsley · University Of Texas Med Br Galveston · N01 · FY2023 · AI